Literature DB >> 23689759

Adult serum cytokine concentrations and the persistence of asthma.

R K Kandane-Rathnayake1, M L K Tang, J A Simpson, J A Burgess, D Mészáros, I Feather, M C Southey, C J Schroen, J Hopper, S C Morrison, G G Giles, E H Walters, S C Dharmage, M C Matheson.   

Abstract

BACKGROUND: Cytokines play a pivotal role in regulating the development and persistence of the inflammatory process in asthma. Our aim was to investigate whether asthma persistence or remission is associated with a specific cytokine profile.
METHODS: The Tasmanian Longitudinal Health Study followed participants from 7 to 44 years of age. Serum concentrations of interleukin (IL)-4, IL-5, IL-6, IL-8, IL-10 and tumor necrosis factor-alpha (TNF-α) were measured at age 44 years. Participants were categorized into five phenotypes (early-onset noncurrent asthma, early-onset current asthma, late-onset noncurrent asthma and late-onset current asthma). Those who had never had asthma formed the reference group. Multivariable linear regression was used to compare serum cytokine concentrations between each phenotype and the reference group.
RESULTS: IL-10 concentrations were significantly lower in serum from the early-onset current asthma group than in the reference group (ratio of geometric means 0.58; 95% confidence interval 0.33-0.99; p = 0.048). IL-6 concentrations for the late-onset remitted group were also significantly lower than in the reference group (p = 0.009). The TNF-α concentrations were significantly lower for both early-and late-onset remitted asthma phenotypes when compared with the reference group. No associations were detected between serum concentrations of IL-4, IL-5 or IL-8 and these specific longitudinal asthma phenotypes.
CONCLUSION: Our findings suggest a possible role for deficient IL-10 responses in the persistence of early-onset asthma. Lower IL-6 and TNF-α concentrations in serum from those with remitted asthma suggest that these proinflammatory cytokines may be actively suppressed during asthma remission.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689759     DOI: 10.1159/000346910

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  4 in total

1.  The Dose-Response Association between Nitrogen Dioxide Exposure and Serum Interleukin-6 Concentrations.

Authors:  Jennifer L Perret; Gayan Bowatte; Caroline J Lodge; Luke D Knibbs; Lyle C Gurrin; Rangi Kandane-Rathnayake; David P Johns; Adrian J Lowe; John A Burgess; Bruce R Thompson; Paul S Thomas; Richard Wood-Baker; Stephen Morrison; Graham G Giles; Guy Marks; James Markos; Mimi L K Tang; Michael J Abramson; E Haydn Walters; Melanie C Matheson; Shyamali C Dharmage
Journal:  Int J Mol Sci       Date:  2017-05-08       Impact factor: 5.923

2.  Interleukin-10 and interleukin-5 balance in patients with active asthma, those in remission, and healthy controls.

Authors:  Minako Tomiita; Eduardo Campos-Alberto; Masayuki Shima; Masanobu Namiki; Kazuo Sugimoto; Hiroyuki Kojima; Hiroko Watanabe; Kunio Sekine; Toshiyuki Nishimuta; Yoichi Kohno; Naoki Shimojo
Journal:  Asia Pac Allergy       Date:  2015-10-28

3.  Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942.

Authors:  Gary Burgess; Malcolm Boyce; Margaret Jones; Lars Larsson; Mark J Main; Frazer Morgan; Peter Phillips; Alison Scrimgeour; Foteini Strimenopoulou; Pavan Vajjah; Miren Zamacona; Roger Palframan
Journal:  EBioMedicine       Date:  2018-08-23       Impact factor: 8.143

4.  Lung function trajectory and biomarkers in the Tasmanian Longitudinal Health Study.

Authors:  Dinh S Bui; Alvar Agusti; Haydn Walters; Caroline Lodge; Jennifer L Perret; Adrian Lowe; Gayan Bowatte; Raisa Cassim; Garun S Hamilton; Peter Frith; Alan James; Paul S Thomas; Debbie Jarvis; Michael J Abramson; Rosa Faner; Shyamali C Dharmage
Journal:  ERJ Open Res       Date:  2021-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.